CSII Company Description
Where do hard hearts and dead limbs go for help? Often the only option for a calcified artery is bypass or amputation. But before the point of no return, Cardiovascular Systems offers a minimally-invasive catheter it developed to help treat a circulatory problem called peripheral arterial disease (PAD). PAD occurs when plaque builds up on vessels, causing decreased blood flow in patients suffering from diabetes or obesity. The company initiated limited manufacture of about 1,700 catheters, which it sold directly to hospitals in the US. It plans to use the proceeds from its IPO to pay off general corporate expenses and for possible acquisitions. The company is 15% owned by its directors and executive officers.
View the Comprehensive Company Description for CSII
The Company Description provides a historical perspective of CSII's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of CSII's evolution in the marketplace.
